IRLAB Therapeutics AB Class A (0GFH) Revenue
IRLAB Therapeutics AB Class A Revenue
IRLAB Therapeutics AB Class A had a revenue of 6.40M in the quarter ending Jun 30, 2026, with -83.73%. This bring the company's revenue in the last twelve months to 79.33M, Decreased 14.20%. In the fiscal year ending Dec 31, 2025, IRLAB Therapeutics AB Class A had annual revenue of 57.46M with -39.28% growth.
- Revenue (ttm)
- 79.33M
- Revenue Growth
- 4.74%
- P/S Ratio
- 5.41
- Revenue/Employee
- SEK 1,853,613
- Employees
- 31
- Market Cap
- SEK 310.81M
Revenue Chart
IRLAB Therapeutics AB Class A Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 57.46M | -37.17M | -39.28% |
| Dec 31, 2024 | 94.63M | 88.95M | 1566.57% |
| Dec 31, 2023 | 5.68M | -55.46M | -90.71% |
| Dec 31, 2022 | 61.14M | -146.65M | -70.58% |
| Dec 31, 2021 | 207.78M | 207.48M | 69160.67% |
| Dec 31, 2020 | 300.00K | 274.00K | 1053.85% |
| Dec 31, 2019 | 26.00K | 8.00K | 44.44% |
| Dec 31, 2018 | 18.00K | -91.00K | -83.49% |
| Dec 31, 2017 | 109.00K | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.